American Heart Journal

Article	Citations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms	229
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study	199
Table of Contents	125
Table of Contents	94
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF	75
Editorial Board	71
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes	58
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network	57
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network	45
Information for Readers	44
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function	42
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial	41
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER	40
Information for Readers	39
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer	37
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease	36
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig	36
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e	35
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	35
Physician responses to apple watch-detected irregular rhythm alerts	34
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States	32
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study	31
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections	31
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism	31
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China	31

Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings	31
Democracy, healthcare, and the public good	30
Rationale and design of a pragmatic randomized clinical trial assessing a smartphone-based digital health intervention in hypertension: The ELFIE-HYPERTENSION trial	30
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial	29
The trial to assess chelation therapy 2 (TACT2): Rationale and design	29
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients	28
Cardiac auscultation skills among medical trainees	28
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study	28
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial	27
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study	27
Cardiovascular Outcomes in Type 2 Diabetes Patients with Inflammatory Polyarthropathy: SGLT2 Inhibitors versus GLP-1 Receptor Agonists	27
Table of Contents	26
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial	26
Single Nucleotide Variants of the MCM6 Gene as a Risk Factor for Metabolically Unhealthy Obesity in Children	25
Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-Human Primates	25
Clinical Data and Diagnostic findings in Patients with Ischemic Heart Disease undergoing Coronary Angiography: a Cross-sectional study from a Tertiary Hospital in Sudan, Africa	25
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement	24
Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study	24
Implementing remote patient monitoring to improve hypertension control in a primary care network: Rationale and design of the monitor-BP Cluster Randomized Trial	24
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry	23
Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey	23
Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification	22
Validity of the International Classification of Diseases, Tenth Revision codes in diagnosing myocardial infarction subtypes	21
Design and rationale of the EMPagliflozin after Aortic Valve Replacement (EMPAVR) study: A randomized clinical trial	21
Design and rational of the the PRACTICAL-HERO trial: A randomized trial of higher and lower doses of heparin vs placebo for elective diagnostic coronary angiography	21
Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators	21
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial	21
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	21
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction	20
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications	20
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy	20
Relationship between left atrial stiffness, pulmonary congestion, and impaired aerobic capacity in adults with repaired coarctation of aorta	20
Diversity of electrocardiographic patterns in left main culprit acute ST-elevation myocardial infarction	20
Enhancing risk stratification for incident systolic heart failure through machine learning and natural language processing	20
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	19
Rheumatoid Arthritis and the Connection with Cardiovascular Disease Mortality	19
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial	19
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinica	19
Prospective randomized comparison between upgraded ‘2C3L’ vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design	19
Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in is	19
Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective rando	18
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial	18
Differences in guideline directed medical therapy for rural and non-rural Veterans with heart failure with reduced ejection fraction	18
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome	18
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	18
A Bayesian re-analysis of the STRESS trial	18
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	18
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design	17
Development of a unified national database of primary percutaneous coronary intervention centers with co-located emergency departments, 2020	17
Information for Readers	17

Editorial Board	17
Efficacy of Liraglutide Versus Gliclazide in Treatment of Patients with Type II Diabetes Mellitus: Systematic Review and Meta-Analysis	17
Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trial	17
Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study	17
GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: Cardiovascular Outcomes and Mortality Benefits	17
Results from a Randomized, Open-Label, Crossover Study Evaluating Pharmacokinetic Interaction Between the Aldosterone Synthase Inhibitor Baxdrostat and Metformin in Healthy Human Subjects	17
Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study	17
Neonatal outcomes of pregnancy in women with congenital heart disease	16
Design and rationale of the Impella®-protected cardiac surgery trial (IMPACT): A multicenter, single-arm pilot study in high-risk cardiac surgery patients	16
Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease	16
ISCHEMIA-EXTEND studies: Rationale and design	16
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis	16
Perioperative bleeding and outcomes after noncardiac surgery	16
Corrigendum to ``Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study''. [Am He	16
Cardiovascular Regulatory Science: Accelerating the Path from Bench to Bedside	16
The effects of low-dose colchicine on the progression of aortic valve stenosis: Rationale, design, and baseline characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial	16
Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic	16
Editorial Board	15
Prediabetes in Takotsubo Syndrome: Impact on Cardiovascular Outcomes and Mortality in a Propensity-Matched Cohort Study	15
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria	15
Benefits of Fiber-Rich Snacks on Waist Circumference and Atergenic Index of Plasma in Obese	15
Information for Readers	15
Clinical Outcomes in Non-Obese Caucasian and Hispanic Populations with DM, a Nation-Wide Study	15
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project	15
Estimate Patient's 10-Years Cardiovascular Risk using Arteriosclerotic Cardiovascular Disease Tool a Cross-Sectional Study in Al-Harja, Asser, Saudi Arabia, 2021	15
Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities	14
The Role of Dialysis in Outcomes of LVAD Implantation in Chronic Kidney Disease Patients: Insights from US National Readmission Database	14
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial	14
Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial	14
Effect of age on restrictive and liberal transfusion outcomes in patients with anemia and myocardial infarction	14
Patterns of diuretic titration during inpatient management of acute decompensated heart failure	14
Familial Hypercholesterolemia and Type 2 Diabetes: Diagnostic and Therapeutic Challenges	14
Early oral anticoagulation monotherapy after PCI: Insights from the POEM trial	14
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial	14
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure	14
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial	14
Towards a person-centered after-visit summary to facilitate improved heart failure care (HF-AVS): A scoping review and call to action	14
Patient characteristics, treatment patterns, and prognosis in drug-use-associated infective endocarditis in Denmark from 1999 to 2018	14
Framework of the strengths and challenges of clinically integrated trials: An expert panel report	14
Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB	14
Enhancing invasive coronary function testing: Multivessel assessment of coronary microvascular dysfunction in patients with angina and no obstructive coronary artery disease (ANOCA)	14
Association of change in QRS duration with chronic heart failure outcomes	14
Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis	13
Extra-virgin olive oil and additional cardiovascular outcomes in the PREDIMED Trial: An outcome-wide perspective	13
Prognostic Value of Triglyceride-Glucose Index for the Prediction of Cardiovascular Events: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)	13
Integration of a task strengthening strategy for hypertension management into HIV care in Nigeria: Baseline characteristics of participants in a cluster randomized controlled trial	13
Rationale and design of European microcirculatory resistance and absolute flow team: The Euro-CRAFT registry	13
Bempedoic Acid for Management of Dyslipidemia from an Indian Perspective: An Expert Consensus Report	13
Complete revascularization in patients with acute myocardial infarction and multivessel disease: Pooled analysis of Kaplan-Meier-derived individual-patient-data	13
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI	13
Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients	13
Trends in urine drug screening and positivity among patients with heart failure: Insights from a large health system	13
Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective	13
Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention	13
Dyslipidaemia Patterns and Risk Factors Among Patients with Diabetes, Hypertension, and Both Diabetes and Hypertension at a Tertiary Hospital in Malawi	13
Table of Contents	13
Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failure	13
Table of Contents	12
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial	12
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE project	12
Sex-differences in 5 year Survival with Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Graft surgery in patients with Diabetes and Multivessel Disease	12
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial	12
Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries	12
Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes	12
The Effect of Avocado Drink (Persea Americana Mill) on the Incidence of Ballooning Hepatocyte in the Liver Organs of Rats (Rattus Novergicus) Induced by Hypercholesterolemia	12
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROT	12
Anatomic and physiologic classification of adults with congenital heart disease to predict adverse outcomes: Use of administrative codes compared to clinical staging	12
Danish-German cardiogenic shock trial—DanGer shock: Trial design update	12
Editorial Board	12
Information for Readers	12
Cardiovascular Risk in Obstructive Sleep Apnea: Impact of Glycemic Control in Diabetes — Insights from the TriNetX Network	12
Relationship Between Vaccines Against Coronavirus Disease 2019 (Covid-19) and Myocarditis	12
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial	12
Editorial Board	12
Editorial Board	12
Empagliflozin and Functional Capacity in Patients at Risk of Heart Failure	12
Editorial Board	12
Self-Medication Practices from the Perspective of Tunisian Cardiovascular Patients – A Community Pharmacy-Based Survey	12
Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design	11
On-treatment blood pressure and cardiovascular mortality in adults with repaired coarctation of aorta	11

Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system	11
Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia	11
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet	11
Lactate Dehydrogenase can be Considered a Predictive Marker of Severity and Mortality of Covid-19 in Diabetic and Non-Diabetic Patients. A Case Series	11
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy	11
Table of Contents	11
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)	11
Associations between practice-level compliance with cardiac performance measures and clinical outcomes in US cardiovascular ambulatory care	11
Precision Profiling of Advanced CVD and CKM Syndrome Through Lipidomics and Immunophenotyping	11
The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart F	11
Transcatheter edge-to-edge repair for chronic functional mitral regurgitation in patients with very severe left ventricular dysfunction	11
Investigating the Smoker's Paradox: Aortic Stenosis Patient Outcomes in Smokers	11
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain	11
Single Nucleotide Variants of the VDR Gene and Cardiometabolic Risk in Obesity	11
Proportion of Obesity-Related Conditions Attributable to Obesity in US Adolescents and Young Adults	11
Risk Scale for Patients with Newly Diagnosed Diabetic Foot Ulcer - Which Patients May Experience Healing Failure or Need Revascularization	11
Outcomes of implantable cardioverter-defibrillator implantation in adults with congenitally corrected transposition of great arteries	10
Meta‐analysis assessing the sensitivity and specificity of 18F‐FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)	10
Central Venous Access: Conventional Seldinger Versus Ultrasound-Guided Technique to Reduce Associated Complications in A School Hospital	10
Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial	10
Prognosis of patients with nonspecific electrocardiogram findings in a Tanzanian emergency department	10
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of	10
Editorial Board	10
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials	10
Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis aged 70 years or younger: A NOTION-2 substudy	10
Enhancing cardiac rehabilitation adherence through home-based rehabilitation and behavioral nudges: The ERA nudge study design and rationale	10
Design and rationale of the HD PCI trial: A cluster randomized crossover trial of higher vs. lower dose heparin for elective percutaneous coronary intervention	10
Incorporating Ensembled Stacked Approach into Automated Machine Learning in an Attempt to Predict Acute Ischemic Heart Disease in Patients with Atypical Chest Pain: Secondary Analysis of a Single-Cent	10
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for h	10
Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration	10
Editorial Board	10
Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE*3-Leiden.CETP Mice	10
Table of Contents	10
Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial	10
Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions	10
Predictors of Major Adverse Limb Events After Infrainguinal Bypass in Patients with Diabetes	10
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-co	10
Design, rationale, and characterization of the mobile health based occupational cardiovascular risk intervention study (mHealth-OPEN study)	10
Table of Contents	10
Hidden in Plain Sight: The Association of Cystic Fibrosis and Diabetic Ketoacidosis- A Nationwide Study	9
Study design for an emulated trial of a 2 arm, parallel, stratified, adaptive, RCT of CABG versus PCI in people requiring myocardial revascularization at high risk (High-Risk REVASC)	9
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study	9
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	9
The contemporary cardio-obstetrics team: The path to improving maternal outcomes in high-risk patients	9
Table of Contents	9
Information for Readers	9
Prognosis of Hospitalizations of Patients with Different Phenotypes of Heart Failure in Type 2 Diabetes Mellitus	9
Editorial Board	9
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial	9
Medicare coverage gap status, adherence to oral anticoagulation, and stroke rates in patients with atrial fibrillation	9
Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction	9
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial	9
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled	9
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study	9
Adiponectin as a Biomarker for Subclinical Atherosclerosis in Obese Adults with Type 2 Diabetes Mellitus	9
Comparative Cardiovascular Outcomes Between Carvedilol and Metoprolol in Patients with Takotsubo Syndrome: A Propensity-Matched Cohort Study	9
The randomized controlled trial to compare temporary permanent pacemaker vs temporary pacemaker in patients with conduction block after transcatheter aortic valve replacement: Rationale and design of	9
Admission with heart failure or atrial fibrillation before mitral valve surgery and associated outcomes	9
Corrigendum to “Accuracy of Site versus Core Laboratory Interpretations of Right Heart Catheterization Hemodynamics” [American Heart Journal:295:107351. AMHJ-D-25-01362 (YMHJ_107351)]	9
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial	9
The Use of Extracorporeal Membrane Oxygenation (ECMO) and Protective Mechanical Ventilation in the Treatment of Acute Respiratory Failure	9
Association Between Glycemic Control and Adverse Outcomes in Atrial Fibrillation: Evidence from a Large Real-World Cohort	9
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia	9
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation	8
Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis	8
Patient characteristics and long-term outcomes in patients undergoing transcatheter aortic valve implantation in a failed surgical prosthesis vs in a native valve: A Danish nationwide study	8
Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry	8
Could paramedics use the HEART Pathway to identify patients at low-risk of myocardial infarction in the prehospital setting?	8
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry	8
Table of Contents	8
Baseline NT-proBNP nonresponse score and health status measures in assessing treatment responses in heart failure with reduced ejection fraction	8
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	8
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry	8
Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action	8
Prevalence and clinical correlates and characteristics of “Super Fontan”	8
Hospital-level variation in cardiac rehabilitation metrics	8
Anatomical, physiological and inflammatory characterization of nonculprit vessels in patients undergoing primary PCI for ST-elevation myocardial infarction in the presence of multivessel disease: Rati	8
The remote exercise SWEDEHEART study–Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT)	8
Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease–2	8
Incremental cost of complications after TAVR and SAVR in contemporary clinical practice	8
Information for Readers	8
Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)	8
The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI – A substudy of the randomized TOTAL trial	8
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design	8
Effect of opt-in versus opt-out framing on trial recruitment: a study within a trial of the GAMEPAD randomized trial	8
Information for Readers	8
Enrollment strategies in the era of digital revolution: Experience from a remote health management program	8
MAFLD and Cardiovascular Disease Risk Assessment in the Primary Care Setting	8
Editorial Board	8
Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry	8
Validation of the ARIC prediction model for sudden cardiac death in the European population: The ESCAPE-NET project	8
The relative merits of using a high-sensitivity cardiac Troponin T assay compared to a nonhigh-sensitivity troponin T assay after noncardiac surgery	8
Biomarkers in Determining the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Hypertension	8
The pathophysiology of patent foramen ovale and its related complications	8
Caribbean and South American team-based strategy to control hypertension (CATCH): Rationale and study design of a cluster randomized trial	8